Business Context and Reporting Period
This Form 6-K filing by Mainz Biomed N.V. (noted as Quantum Cyber N.V. in metadata) covers the month of October 2024, specifically dated October 9, 2024. The report details the entry into a material definitive agreement, specifically a Second Supplemental Agreement with YA II PN, Ltd. ("Yorkville"), amending a Pre-Paid Advance Agreement (PPA) originally entered into in June 2023.
Key Financial Metrics and Debt Structure
The filing focuses on debt obligations and liquidity arrangements rather than operational revenue or profit metrics, which are not provided in this text.
- Existing Debt Balance: As of the filing date, the outstanding balance on the First, Second, and Third Notes issued to Yorkville is approximately $3,037,334.46.
- New Debt Issuance: The Company issued a Fourth Promissory Note with an original principal amount of $1,500,000 on October 8, 2024.
- Fourth Note Terms:
- Original Issue Discount: 10%.
- Interest Rate: 7% per annum (increases to 15% per annum upon an event of default).
- Maturity: One year from issuance.
- Prepayment: Allowed with a 5% premium subject to notice periods.
- Conversion: Convertible at Yorkville's discretion at the lower of $0.25 per share or 92% of the average of the two lowest daily VWAPs during the preceding eight trading days.
- Repayment Schedule: The Company agreed to make monthly payments of $750,000 in aggregate principal across all promissory notes issued to Yorkville until fully repaid. These payments include accrued but unpaid interest.
Material Changes Versus Prior Period
The primary material change is the amendment of the existing debt structure through the Second Supplemental Agreement:
- Extension of Maturity: The maturity date for all Existing Notes (First, Second, and Third) has been extended to June 30, 2025.
- Amended Conversion Terms: The conversion price and floor price for the Existing Notes have been amended as defined in the Second Supplemental Agreement.
- Increased Leverage: The issuance of the Fourth Note adds $1,500,000 in new principal debt to the existing obligations.
Outlook, Risks, and Contingencies
The filing highlights significant financial risks and contingencies associated with the debt instruments:
- Default Risk: An event of default triggers an interest rate increase on the Fourth Note from 7% to 15% per annum.
- Dilution Risk: The Fourth Note and Existing Notes are convertible into ordinary shares. The conversion price mechanism (lower of $0.25 or a discounted VWAP) creates potential for significant dilution to existing shareholders.
- Liquidity Pressure: The mandatory monthly principal repayment of $750,000 imposes a strict cash flow requirement on the Company.
- Prepayment Penalty: Early repayment of the Fourth Note incurs a 5% premium.
Key Facts for Investor Verification
- Verify the Company's current cash position and ability to meet the mandatory $750,000 monthly principal payments.
- Confirm the exact amended conversion prices and floor prices for the Existing Notes as detailed in the filed Exhibit 10.1.
- Assess the potential dilution impact if Yorkville exercises its conversion rights on the Fourth Note at the $0.25 floor price.
- Review the full text of the Second Supplemental Agreement (Exhibit 10.1) and Fourth Note (Exhibit 10.2) for specific definitions of "event of default."
- Note that this filing does not provide revenue, profit, or operating cash flow data; investors should refer to the most recent Form 20-F for operational metrics.